152 related articles for article (PubMed ID: 19154409)
1. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.
Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N
Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409
[TBL] [Abstract][Full Text] [Related]
2. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.
Popivanova BK; Li YY; Zheng H; Omura K; Fujii C; Tsuneyama K; Mukaida N
Cancer Sci; 2007 Mar; 98(3):321-8. PubMed ID: 17270021
[TBL] [Abstract][Full Text] [Related]
4. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
Dai H; Li R; Wheeler T; Diaz de Vivar A; Frolov A; Tahir S; Agoulnik I; Thompson T; Rowley D; Ayala G
Prostate; 2005 Nov; 65(3):276-86. PubMed ID: 16015593
[TBL] [Abstract][Full Text] [Related]
5. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
[TBL] [Abstract][Full Text] [Related]
6. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the human Cdc2l2 gene promoter.
Feng Y; Goulet AC; Nelson MA
Gene; 2004 Apr; 330():75-84. PubMed ID: 15087126
[TBL] [Abstract][Full Text] [Related]
8. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
9. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
10. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
[TBL] [Abstract][Full Text] [Related]
11. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
13. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
[TBL] [Abstract][Full Text] [Related]
14. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
[TBL] [Abstract][Full Text] [Related]
15. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
16. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
17. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line.
Kita D; Takino T; Nakada M; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Nov; 61(21):7985-91. PubMed ID: 11691823
[TBL] [Abstract][Full Text] [Related]
18. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract][Full Text] [Related]
19. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
[TBL] [Abstract][Full Text] [Related]
20. A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.
Li S; Xi Y; Zhang H; Wang Y; Wang X; Liu H; Chen K
Oncol Rep; 2010 Oct; 24(4):997-1004. PubMed ID: 20811681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]